Skip to main content

Tagged With "patch"

Comment

Re: Food Allergy Treatments Show Promising Results

josephine ·
As a mother of a son (age 11) who has been dealing with this allergy combo. since one, I agree with this article. We also have contact and air borne to same which just adds to it all. The important thing to remember is to read, read and read and know about everything that goes into your child's mouth. Cooking things at home is major too. My dream is that they will find a cure to all food allergies and to find resturants that actually can come up with something for my child to eat besides...
Blog Post

DBV Submits Viaskin Peanut Treatment for FDA Biologics License

KFA News Team ·
DBV Technologies today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Viaskin Peanut for the treatment of peanut allergy in children four to 11 years of age. Viaskin Peanut is the Company’s lead product candidate, which is based on epicutaneous immunotherapy (EPIT), a proprietary technology platform that delivers biologically active compounds to the immune system
Blog Post

FDA Gives Experimental Peanut Allergy Patch Special Status Designed to Speed Review

Kids With Food Allergies ·
The Food and Drug Administration agreed to review a skin patch for peanut allergy on an expedited basis following positive results of recent clinical trials, the company said Thursday.   DBV Technologies said that the FDA granted its Viaskin...
Blog Post

FDA Application for Peanut Patch for Children 4 to 11 Years of Age Is Withdrawn

KFA News Team ·
DBV Technologies today announced that after discussions with the U.S. Food and Drug Administration (FDA), its Biologics License Application (BLA) for Viaskin Peanut in children four to 11 years of age has been voluntarily withdrawn. DBV is currently working closely with the agency to resubmit the application for Viaskin Peanut as quickly as possible.
Blog Post

DBV Resubmits Viaskin Peanut Allergy Treatment to FDA

KFA News Team ·
DBV Technologies, a clinical-stage biopharmaceutical company, today announced the submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Viaskin® Peanut for the treatment of peanut-allergic children ages 4 to 11 years.
Blog Post

Food Allergy Research Roundup 2017 Quarter 1

KFA News Team ·
Kids With Food Allergies will recap some of the top research in food allergies every three months. Here is a look at studies reported between January and March. Read about teens and food allergy, peanut allergy, secondhand smoke and more.
Blog Post

Food Allergy Research Update: Viaskin Study for Peanut Allergy

KFA News Team ·
Press Release: Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin(r) Peanut in Treatment of Peanut Allergy Leading US centers in food allergy involved in an NIH-funded CoFAR6 study,...
Blog Post

Food Allergy Treatments Show Promising Results

KFA News Team ·
A report from NBCNews explains two new treatments being studied: multiple food oral immunotherapy and a new skin patch. The treatments involve exposing the patient to a small amount of their allergen and slowly increasing the dose to build up...
Blog Post

Peanut Patch Could Be Game Changer

Kids With Food Allergies ·
Now, doctors at New York's Mount Sinai Hospital and 23 other hospitals worldwide are testing what they hope will be a breakthrough treatment. It is a patch that exposes the wearer to small amounts of peanut protein through the skin. Over time, they...
Blog Post

Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Kids With Food Allergies ·
Epicutaneous Immunotherapy (EPIT) introduces new way to treat peanut allergies   (Press Release)   Houston, TX – A team of researchers unveiled the results of their highly anticipated multi-national, double-blind, placebo controlled...
Comment

Re: Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

jmw ·
How long until this becomes an available option??
Comment

Re: Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Kathy P ·
I don't think they know how long yet. It's still in clinical trials.
Comment

Re: Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

SarahRoseAZ ·
I will be watching this like a hawk...My son has had the peanut allergy all his life along with non verbal autism...getting rid of this allergy is hugely important to me due to him someday living in a group home type setting and not having to worry about the staff feeding him the wrong thing and killing him....the autism I can handle...its not going to kill him, but the peanuts will.
Comment

Re: Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Kathy P ·
I can see where a food allergy would be a huge challenge in that type of environment!
Comment

Re: Peanut Patch Could Be Game Changer

Hamadred ·
This could be life changing for so many people. I can't wait to see how this develops!
Comment

Re: FDA Gives Experimental Peanut Allergy Patch Special Status Designed to Speed Review

Abigail's Mommy ·
How can we find a Phase III trial? I'm interested in doing this.
Comment

Re: FDA Gives Experimental Peanut Allergy Patch Special Status Designed to Speed Review

StephC ·
Same here. And how do we get notified about trials for milk?
Blog Post

Viaskin™ Peanut Patch Not Approved in Its Present Form - DBV to Request Meeting With FDA

KFA News Team ·
DBV Technologies, a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the Company’s Biologics License Application (BLA) for investigational Viaskin™ Peanut (DBV712), a non-invasive, once-daily epicutaneous patch to treat peanut allergies in children ages 4 to 11 years.
Comment

Re: Viaskin™ Peanut Patch Not Approved in Its Present Form - DBV to Request Meeting With FDA

Juneau ·
We have been looking forward to this patch for years and my kid may be too old by the time it gets approved. So much safer than other peanut allergy treatments.
Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)
-->
×
×
×
×